Adjuvant nivolumab in resected oesophageal or gastroesophageal junction cancer following neoadjuvant chemoradiotherapy: Slovenian real-world data
Adjuvant nivolumab has become the new standard of care for patients with oesophageal and gastroesophageal junction cancer (OEC/GEJC) following neoadjuvant chemoradiotherapy (neoCRT) and surgical resection. In Slovenia, this treatment has been in use since January 2022. Here, we report the first Slov...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Sciendo
2026-04-01
|
| coleção: | Radiology and Oncology |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.2478/raon-2026-0020 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|